{"id":1454,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2005-10-06","marketCap":353.53594970703125,"name":"Altimmune Inc","phone":"12406541450.0","outstanding":53.72999954223633,"symbol":"ALT","website":"https://altimmune.com/","industry":"Biotechnology"},"price":7.106675,"year":2023,"month":12,"day":8,"weekday":"Friday","title":"The Impact of Currency Fluctuations on Altimmune Inc Multinational Stock","date":"2023-12-08","url":"/posts/2023/12/08/ALT","content":[{"section":"Introduction","text":"Altimmune Inc is a multinational company that operates in various countries, making it vulnerable to currency fluctuations. These fluctuations occur due to changes in exchange rates between different currencies. They can impact Altimmune Inc's stock value and financial performance."},{"section":"Positive Impact","text":"Currency fluctuations can have a positive impact on Altimmune Inc's multinational stock. If the company's earnings are denominated in a currency that strengthens against other currencies, the value of its earnings in the home currency could increase. This can lead to higher stock prices as investors perceive increased profitability. Additionally, when the company repatriates profits from a country with a weaker currency, it can benefit from the favorable exchange rate, resulting in higher returns for shareholders."},{"section":"Negative Impact","text":"On the other hand, currency fluctuations can also have a negative impact on Altimmune Inc's multinational stock. If the company's home currency strengthens against the currencies in which it operates, its foreign earnings when translated into the home currency may decrease. This can result in lower stock prices as investors anticipate reduced profitability. Currency fluctuations can also increase the costs of raw materials and production for the company, leading to lower margins and negatively affecting the stock value."},{"section":"Case Study 1: Brexit and the British Pound","text":"One real-world case study illustrating the impact of currency fluctuations on multinational stocks is the Brexit vote and the subsequent depreciation of the British pound. Altimmune Inc, which operates in the UK, would have experienced a negative impact on its stock value due to the decline in the pound. This depreciation made its UK operations less profitable when translated into the home currency, potentially leading to a decline in stock prices."},{"section":"Case Study 2: US Dollar Strengthening","text":"Another case study involves the strengthening of the US dollar against other currencies. If Altimmune Inc generates significant revenues from markets with weakening currencies, such as emerging economies, the translation of these earnings into US dollars would lead to a decrease in value. This could result in a negative impact on the company's stock price."},{"section":"Conclusion","text":"Currency fluctuations present both opportunities and risks for Altimmune Inc's multinational stock. While they can potentially increase profitability and stock value, they can also lead to decreased earnings and lower stock prices. It is crucial for Altimmune Inc to actively manage currency risk through hedging strategies and closely monitor foreign exchange markets to mitigate potential losses and maximize returns for shareholders."}],"tags":["CrossOver100","Long","Biotechnology"],"news":[{"category":"company","date":1701952380,"headline":"Altimmune's stock pops as analysts see obesity-drug partnership potential","id":124375158,"image":"https://images.mktw.net/im-520633/social","symbol":"ALT","publisher":"MarketWatch","summary":"Altimmune shares have jumped this week as analysts see potential for the company to find a partner for its experimental weight-loss drug.","url":"https://www.marketwatch.com/story/altimmune-shares-pop-as-analysts-see-obesity-drug-partnership-potential-524ea4f4"},{"category":"company","date":1701951300,"headline":"Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":124364215,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246254507"},{"category":"company","date":1701949140,"headline":"Altimmune’s stock pops as analysts see obesity-drug partnership potential","id":124372648,"image":"","symbol":"ALT","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246200316"},{"category":"company","date":1701948840,"headline":"Altimmune shares pop as analysts see obesity-drug partnership potential","id":124372649,"image":"","symbol":"ALT","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246193992"},{"category":"company","date":1701941100,"headline":"Altimmune call volume above normal and directionally bullish","id":124372650,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246017505"},{"category":"company","date":1701940740,"headline":"Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday","id":124360579,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3246010563"},{"category":"company","date":1701935100,"headline":"Largest borrow rate increases among liquid names","id":124360145,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3245891277"},{"category":"company","date":1701863040,"headline":"ALT, SYRS and PHIO among mid-day movers","id":124336953,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244330252"},{"category":"company","date":1701862380,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":124338947,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244316922"},{"category":"company","date":1701858600,"headline":"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities","id":124335404,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244227464"},{"category":"company","date":1701852561,"headline":"Altimmune: Don't Buy The GLP-1 Move-Up","id":124330152,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1584964652/image_1584964652.jpg?io=getty-c-w1536","symbol":"ALT","publisher":"SeekingAlpha","summary":"Altimmune's recent MOMENTUM data is not as strong as it seems. Read more to see an overview and analysis of ALT stock.","url":"https://seekingalpha.com/article/4656289-altimmune-dont-buy-the-glp-1-move-up"},{"category":"company","date":1701852000,"headline":"Unusually active option classes on open December 6th","id":124333043,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244076262"},{"category":"company","date":1701848820,"headline":"Altimmune price target raised to $15 from $8 at B. Riley","id":124347516,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244009456"},{"category":"company","date":1701848280,"headline":"TGTX, IBIO and ALT are among pre market gainers","id":124332343,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3243997053"},{"category":"company","date":1701841109,"headline":"Altimmune: Pemvidutide Data Reinforces Obesity Drug Outlook","id":124328476,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1816294395/image_1816294395.jpg?io=getty-c-w1536","symbol":"ALT","publisher":"SeekingAlpha","summary":"Altimmune has made a good amount of progress in being able to advance pemvidutide for the treatment of patients with obesity and NASH. Find out why ALT stock is a Buy.","url":"https://seekingalpha.com/article/4656263-altimmune-pemvidutide-data-reinforces-obesity-drug-outlook"},{"category":"company","date":1701836104,"headline":"PRISM MarketView Highlights Altimmune's Positive Topline Results in Obesity Drug Trial","id":124327792,"image":"","symbol":"ALT","publisher":"Finnhub","summary":"New York, N.Y. - PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Altimmune, Inc. which has reported positive topline results from its 48-week MOMENTUM...","url":"https://finnhub.io/api/news?id=13bce13cfd93f6c0cef5c2cda65734fccfed07ff5b56e58dd8fd174b60db1d8c"},{"category":"company","date":1701834240,"headline":"ALT, CONN and VRNT are among after hour movers","id":124343960,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244695865"},{"category":"company","date":1701827220,"headline":"Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session","id":124339785,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244515708"},{"category":"company","date":1701782354,"headline":"Altimmune open to partnerships, deals with drugmakers, says CEO","id":124308107,"image":"","symbol":"ALT","publisher":"Finnhub","summary":"Weight-loss drug developer Altimmuneis open to deals and collaborations with largedrugmakers as it actively looks for partners to launch anddevelop its experimental obesity drug, CEO Vipin Garg...","url":"https://finnhub.io/api/news?id=587c9c2a39382d235a029e7993ebd4000a479795fc519d6768dbd3d18999a84f"},{"category":"company","date":1701774540,"headline":"While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer","id":124309778,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242421421"},{"category":"company","date":1701763740,"headline":"Top 5 Health Care Stocks That Are Ticking Portfolio Bombs","id":124303397,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3242187858"},{"category":"company","date":1701692220,"headline":"Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session","id":124281652,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240772662"},{"category":"company","date":1701689700,"headline":"12 Health Care Stocks Moving In Monday's Intraday Session","id":124282819,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240716655"},{"category":"company","date":1701687540,"headline":"Viking Therapeutics rises on Roche acquiring peer Carmot","id":124279780,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240667732"},{"category":"company","date":1701685500,"headline":"Weight-loss drug developers rise after Roche agrees to buy Carmot","id":124279739,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240625716"},{"category":"company","date":1701684480,"headline":"Biotech Alert: Searches spiking for these stocks today","id":124283362,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240604843"},{"category":"company","date":1701678900,"headline":"Water Tower Research US Climate Investor Conference Agenda Announced for December 7th, 2023","id":124279195,"image":"","symbol":"ALT","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=m9447vbwl9"},{"category":"company","date":1701677640,"headline":"Altimmune price target raised to $16 from $10 at Guggenheim","id":124291549,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240468603"},{"category":"company","date":1701672060,"headline":"Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Atricure (ATRC)","id":124287406,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240373510"},{"category":"company","date":1701665460,"headline":"Roche ventures into weight-loss drug market with $2.7B buyout of Carmot","id":124279786,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3240283316"},{"category":"company","date":1701660180,"headline":"Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market","id":124291552,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3241026254"},{"category":"company","date":1701434280,"headline":"Altimmune Stock (NASDAQ:ALT) Rallies on Positive Obesity Drug Results","id":124238380,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236539367"},{"category":"company","date":1701431640,"headline":"HTOO and PIXY among mid-day movers","id":124229138,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237188225"},{"category":"company","date":1701430560,"headline":"Altimmune’s Pemvidutide Shows Promising Obesity Treatment Potential with Strong Market Prospects","id":124238383,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237166455"},{"category":"company","date":1701430560,"headline":"12 Health Care Stocks Moving In Friday's Intraday Session","id":124229139,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237166576"},{"category":"company","date":1701429660,"headline":"Altimmune price target raised to $25 from $16 at JMP Securities","id":124238384,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237147634"},{"category":"company","date":1701429120,"headline":"Why Is Hub Cyber Security (HUBC) Stock Up 30% Today?","id":124232536,"image":"","symbol":"ALT","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237134781"},{"category":"company","date":1701428880,"headline":"Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session","id":124227398,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237131285"},{"category":"company","date":1701427560,"headline":"Why Is Altimmune (ALT) Stock Up 43% Today?","id":124232540,"image":"","symbol":"ALT","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3237104161"},{"category":"company","date":1701422220,"headline":"Altimmune weight-loss drug performed better than rivals, says JMP","id":124235549,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236998200"},{"category":"company","date":1701421860,"headline":"Biggest stock movers today: Pfizer, Dell Technologies, Ulta Beauty, UiPath and more","id":124229394,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236990104"},{"category":"company","date":1701420000,"headline":"Unusually active option classes on open December 1st","id":124229811,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236955036"},{"category":"company","date":1701417480,"headline":"Fly Intel: Pre-market Movers","id":124225597,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236907983"},{"category":"company","date":1701414780,"headline":"12 Health Care Stocks Moving In Friday's Pre-Market Session","id":124225369,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236860419"},{"category":"company","date":1701414360,"headline":"Buy Rating Affirmed for Altimmune on Pemvidutide’s Promising Obesity and NASH Treatment Potential","id":124238393,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236853940"},{"category":"company","date":1701414300,"headline":"'Impressive' Altimmune data likely drives strategic interest, says B. Riley","id":124235552,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236853029"},{"category":"company","date":1701413100,"headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday","id":124225370,"image":"","symbol":"ALT","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236832011"},{"category":"company","date":1701411360,"headline":"Pfizer pulls back from twice-daily regime of weight-loss drug candidate","id":124232560,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236805354"},{"category":"company","date":1701404700,"headline":"Biggest stock movers today: Ulta Beauty, UiPath and more","id":124238397,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236708473"},{"category":"company","date":1701379440,"headline":"Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide","id":124218339,"image":"https://media.zenfs.com/en/globenewswire.com/f005196d589b970c455242e216543738","symbol":"ALT","publisher":"Yahoo","summary":"Achieved mean weight loss of 15.6% on 2.4 mg dose of pemvidutide at Week 48, with weight loss continuing at the end of treatmentOver 30% of subjects achieved 20% or more weight loss on 2.4 mg dose at 48 weeks Robust reductions in BMI and serum lipids and improvements in blood pressure without imbalances in cardiac events, arrhythmias or clinically meaningful increases in heart rate Altimmune to host conference call tomorrow at 8:30 am EST GAITHERSBURG, Md., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Alti","url":"https://finance.yahoo.com/news/altimmune-announces-positive-topline-results-212400306.html"},{"category":"company","date":1701362520,"headline":"Altimmune’s stock soars more than 40% after biopharma company says trial of obesity drug led to weight loss","id":124257415,"image":"https://s.wsj.net/public/resources/MWimages/MW-GP644_MicroS_ZG_20180906154215.jpg","symbol":"ALT","publisher":"MarketWatch","summary":"Altimmune Inc. shares rallied more than 40% in the extended session Thursday after the clinical-stage biopharma company said 391 people enrolled in a trial...","url":"https://www.marketwatch.com/story/altimmunes-stock-soars-more-than-40-after-biopharma-company-says-trial-of-obesity-drug-led-to-weight-loss-182c7ec1"},{"category":"company","date":1701336180,"headline":"IN BRIEF: Altitude Group non-exec director sells GBP225,000 in shares","id":124202244,"image":"","symbol":"ALT","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=hm823wf4ai"},{"category":"company","date":1701329760,"headline":"Buy Rating for Altimmune: Pemvidutide Outperforms Competitors with Superior Efficacy and Safety Profile","id":124238399,"image":"","symbol":"ALT","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3236109949"},{"category":"company","date":1701318420,"headline":"Altimmune soars 34% on phase 2 obesity drug data","id":124238400,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3235775992"},{"category":"company","date":1701317760,"headline":"ALT, CARM and WOOF are among after hour movers","id":124235873,"image":"","symbol":"ALT","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3235759098"},{"category":"company","date":1701315180,"headline":"Altimmune announces results from 48-week MOMENTUM obesity trial","id":124238404,"image":"","symbol":"ALT","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3235685810"},{"category":"company","date":1701315180,"headline":"12 Health Care Stocks Moving In Thursday's After-Market Session","id":124214344,"image":"","symbol":"ALT","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3235685932"},{"category":"company","date":1701160200,"headline":"Alternus Energy Reports Third Quarter 2023 Financial Results","id":124144152,"image":"","symbol":"ALT","publisher":"GlobeNewswire","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=c5isurwmxg"},{"category":"company","date":1701135060,"headline":"GET READY: easyJet, Pets at Home, Greencore, Treatt at 0700 GMT","id":124143592,"image":"","symbol":"ALT","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=p8d8itswzc"},{"category":"company","date":1701078540,"headline":"UK earnings, trading statements calendar - next 7 days","id":124123670,"image":"","symbol":"ALT","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=439kgbrtci"},{"category":"company","date":1701067745,"headline":"Altimmune (ALT) Price Target Increased by 9.39% to 19.53","id":124117730,"image":"","symbol":"ALT","publisher":"Fintel","summary":"","url":"https://fintel.io/news/altimmune-alt-price-target-increased-by-939-to-1953-501"}]}